← back to search

Silvio Nadalin

The University of Tokyo · DE
Area of research
Surgery · Hepatology
Research interest
Research interests include Organ Transplantation Techniques and Outcomes, Liver Disease and Transplantation, Hepatocellular Carcinoma Treatment and Prognosis, and Renal Transplantation Outcomes and Treatments.
h-index
54
citations
11,019
works
407
NIH funding
primary concept
Medicine
email

Recent publications

Liver transplantation in well-selected patients with unresectable colorectal liver metastases.
2026cited by 1position: contributordoi
Liver transplantation for refractory portal hypertension syndrome due to intrahepatic arterioportal shunts after treatment of primary hepatic choriocarcinoma: A case report.
2026cited by 0position: contributordoi
Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model.
2026cited by 0position: contributordoi
Deceased donor liver utilisation and assessment: Consensus guidelines from the European Liver and Intestine Transplant Association
Journal of Hepatology 2025cited by 27position: middledoi
Deceased donor liver utilisation and assessment: Consensus guidelines from the European Liver and Intestine Transplant Association
Journal of Hepatology 2025cited by 27position: contributordoi
Self-Reported Outcome of Living Kidney Donation Correlates With Perioperative Complications not With Surgical Techniques
Kidney International Reports 2025cited by 3position: middledoi
Histologic Ex Vivo Validation of the [<sup>18</sup>F]SITATE Somatostatin Receptor PET Tracer
Journal of Nuclear Medicine 2025cited by 1position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Zeitschrift für Gastroenterologie 2025cited by 1position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion
Zeitschrift für Gastroenterologie 2025cited by 1position: middledoi
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Zeitschrift für Gastroenterologie 2025cited by 1position: middledoi
Kidney Transplantation in Case of Renal Graft with Multiple Arteries: Challenges and Long-Term Results of Microsurgical Anastomosis Between Lower Polar Renal Artery and Inferior Epigastric Artery.
2025cited by 1position: contributordoi
Renal Autotransplantation for Resection of Bilateral Nephroblastoma and High-Risk Neuroblastoma in Children.
2025cited by 0position: contributordoi
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Kurzversion
Zeitschrift für Gastroenterologie 2025cited by 0position: middledoi
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible
Annals of Surgical Oncology 2024cited by 31position: middledoi
Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases
American Journal of Transplantation 2024cited by 27position: contributordoi
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort
Annals of Surgical Oncology 2024cited by 10position: middledoi
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Zeitschrift für Gastroenterologie 2024cited by 8position: middledoi
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
Frontiers in Endocrinology 2024cited by 5position: middledoi
Current management of symptomatic vesicoureteral reflux in pediatric kidney transplantation-A European survey among surgical transplant professionals.
2024cited by 4position: contributordoi
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
Zeitschrift für Gastroenterologie 2024cited by 3position: middledoi
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Zeitschrift für Gastroenterologie 2024cited by 3position: middledoi
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
Zeitschrift für Gastroenterologie 2024cited by 1position: middledoi
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Journal of Hepatology 2023cited by 40position: middledoi
Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
British journal of surgery 2023cited by 39position: middledoi
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
Transplant International 2023cited by 38position: lastdoi
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation
Hepatology 2023cited by 35position: middledoi
Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation—A Retrospective Multicenter Outcome Analysis
Transplantation 2023cited by 10position: middledoi
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
HPB 2023cited by 8position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Zeitschrift für Gastroenterologie 2023cited by 4position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
Zeitschrift für Gastroenterologie 2023cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2021–2026)Andreas Pascher · University of Münster6 papers (2013–2018)Hauke Lang · Johannes Gutenberg University Mainz5 papers (2012–2023)Frank Lehner · Fachhochschule Wiener Neustadt5 papers (2014–2018)Hans J. Schlitt · University Hospital Regensburg4 papers (2012–2018)Johann Pratschke · Johnson & Johnson (United States)4 papers (2018–2023) · 4 papers (2014–2022)Alfred Königsrainer · University Children's Hospital Tübingen4 papers (2012–2024)Peter Schemmer · Medical University of Graz4 papers (2013–2018)Andreas A. Schnitzbauer · University Hospitals of the Ruhr-University of Bochum4 papers (2012–2023)Pim B. Olthof · Seattle University3 papers (2020–2023) · 3 papers (2014–2022)William R. Jarnagin · Weill Cornell Medicine3 papers (2020–2023)Martina Sterneck · Johannes Gutenberg University Mainz3 papers (2014–2016)Marcus N. Scherer · Johannes Gutenberg University Mainz3 papers (2012–2016)Lutz Fischer · University of Birmingham3 papers (2014–2021)Ulrich Baumann · Medizinische Hochschule Hannover3 papers (2020–2023)Bas Groot Koerkamp · Erasmus MC3 papers (2020–2023) · 3 papers (2020–2023)Francesca Ratti · Vita-Salute San Raffaele University2 papers (2021–2023)